Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03059069
PHASE4

The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients

Sponsor: Yonsei University

View on ClinicalTrials.gov

Summary

The aim of this study is to investigate the effect of Gliatamin (chonline alphoscerate) on depressive mood in type 2 diabetes patients and demonstrate the impact of improved depressive mood could be influence the patient's quality of life and glycemic control.

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2016-06-01

Completion Date

2025-06-30

Last Updated

2025-02-24

Healthy Volunteers

No

Interventions

DRUG

Chonline Alphoscerate

Patients treated with Chonline Alphoscerate as add on therapy to their medication

DRUG

Placebo Oral Tablet

Patients maintain their medication with either Gliatamin or placebo for 6 months.

Locations (1)

Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center

Seoul, South Korea